EIF4A3-IN-7

• Description:

  EIF4A3-IN-7 is a potent inhibitor of eIF4A3. eIF4A3-IN-7 has the potential for researching cancer and other dysproliferative diseases (extracted from patent WO2019161345A1, Compound 8) [1].

• UNSPSC:

  12352005

• Target:

  Eukaryotic Initiation Factor (eIF)

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/eif4a3-in-7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O[C@]12[C@] (OC3=CC (OC) =CC (OC) =C32) (C4=CC=C (C=C4) O) [C@@] (C5=CC=CC=C5) ([H]) [C@H] ([C@H]1O) C (N) =O

• Molecular Formula:

  C26H25NO7

• Molecular Weight:

  463.48

• References & Citations:

  [1]Yoshiyuki Fukase, et al. Agents and methods for treating dysproliferative diseases. Patent WO2019161345A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  EIF4

• CAS Number:

  2374759-82-5